ACELYRIN, INC Common Alpha and Beta Analysis

SLRNDelisted Stock  USD 2.27  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ACELYRIN, INC Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in ACELYRIN, INC over a specified time horizon. Remember, high ACELYRIN, INC's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ACELYRIN, INC's market risk premium analysis include:
Beta
(0.27)
Alpha
0.2
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although ACELYRIN, INC alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, ACELYRIN, INC did 0.20  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of ACELYRIN, INC Common stock's relative risk over its benchmark. ACELYRIN, INC Common has a beta of 0.27  . As returns on the market increase, returns on owning ACELYRIN, INC are expected to decrease at a much lower rate. During the bear market, ACELYRIN, INC is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

ACELYRIN, INC Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ACELYRIN, INC market risk premium is the additional return an investor will receive from holding ACELYRIN, INC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ACELYRIN, INC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ACELYRIN, INC's performance over market.
α0.20   β-0.27

ACELYRIN, INC Fundamentals Vs Peers

Comparing ACELYRIN, INC's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ACELYRIN, INC's direct or indirect competition across all of the common fundamentals between ACELYRIN, INC and the related equities. This way, we can detect undervalued stocks with similar characteristics as ACELYRIN, INC or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ACELYRIN, INC's fundamental indicators could also be used in its relative valuation, which is a method of valuing ACELYRIN, INC by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare ACELYRIN, INC to competition
FundamentalsACELYRIN, INCPeer Average
Return On Equity-0.51-0.31
Return On Asset-0.3-0.14
Current Valuation(175.46 M)16.62 B
Shares Outstanding100.95 M571.82 M
Shares Owned By Insiders7.15 %10.09 %
Shares Owned By Institutions91.97 %39.21 %
Number Of Shares Shorted3.57 M4.71 M

ACELYRIN, INC Opportunities

ACELYRIN, INC Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Is Acelyrin, Inc. the Best Micro Cap Stock to Buy Now
03/07/2025
2
Disposition of 3211 shares by Mpofu Shephard of ACELYRIN, INC at 2.744 subject to Rule 16b-3
03/17/2025
3
Insider Selling Acelyrin, Inc. Insider Sells 3,913 Shares of Stock
03/19/2025
4
Shares of RH Down Nearly 40 percent Where Investors Can Turn To Now - The Globe and Mail
04/03/2025
5
ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin...
04/16/2025
6
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis
05/01/2025
7
Acquisition by Svoronos Dawn of 23243 shares of ACELYRIN, INC at 18.0 subject to Rule 16b-3
05/09/2025
8
Alumis Inc. Reports First Quarter 2025 Financial Results - TradingView
05/14/2025

About ACELYRIN, INC Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ACELYRIN, or other delisted stocks. Alpha measures the amount that position in ACELYRIN, INC Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

ACELYRIN, INC Upcoming Company Events

As portrayed in its financial statements, the presentation of ACELYRIN, INC's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ACELYRIN, INC's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ACELYRIN, INC's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ACELYRIN, INC. Please utilize our Beneish M Score to check the likelihood of ACELYRIN, INC's management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
20th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with ACELYRIN, INC

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in ACELYRIN, Stock

If you are still planning to invest in ACELYRIN, INC Common check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACELYRIN, INC's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Managers
Screen money managers from public funds and ETFs managed around the world